Jennifer Brusko
The COVID-19 pandemic has presented unprecedented challenges to healthcare systems worldwide. In severe cases, the virus can lead to Acute Respiratory Distress Syndrome (ARDS), necessitating advanced interventions such as Extracorporeal Membrane Oxygenation (ECMO). ECMO provides temporary mechanical support to the heart and lungs, allowing them to rest and heal. However, determining the success of ECMO in COVID-19 patients has become a critical concern. Lung ultrasound, a non-invasive imaging technique, has gained traction as a potential tool for predicting the success of ECMO in these patients. This article delves into the application of lung ultrasound in predicting the outcomes of COVID-19 patients undergoing ECMO.
ఈ కథనాన్ని భాగస్వామ్యం చేయండి
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 